Islet Sciences, Inc. is focused on improving patient outcomes by developing new medicines and technologies for the treatment of metabolic diseases. The Company’s pipeline includes small molecule therapeutics, cell therapy based artificial pancreas, and a molecular diagnostic to detect the onset of insulin dependent diabetes. 

Islet Sciences, Inc. is developing new medicines and technologies for the treatment of metabolic disease. The Company is developing an encapsulated islet cell transplantation therapy for the treatment of insulin-dependent diabetes; first-in-class immune-modulating small molecule IL-12 inhibitors that protect insulin-producing beta-cells from cytokines responsible for cell destruction; and a PCR based molecular diagnostic measuring hypomethylated beta cell-derived DNA as a biomarker of beta cell loss for the diagnosis of type 1 diabetes or onset of insulin dependent type 2 diabetes. 


 

latest news

08.06.2014

Islet Sciences, Inc. Receives Notice of Allowance for U.S. Patent Covering Novel IL-12 Inhibitors  
VIEW PDF 

07.16.2014
Islet Sciences, Inc. Announces Peer-Reviewed Publication of Study Validating Novel Diabetes Diagnostic  
VIEW PDF 

06.24.13

Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
READ MORE

05.10.13
Islet Sciences Article in Insulin Nation Titled “A Type 1 Triple Play”
READ MORE

05.07.13
Islet Sciences Highlights Abstract at Arteriosclerosis, Thrombosis & Vascular Biology ATVB 2013
READ MORE

04.29.13
Islet Sciences Reviews Japanese Patent Covering New Medication for Diabetes.
READ MORE

 

04.03.13
Islet Sciences Receives Notice of Claims Allowance for U.S. Patent Application for New Medications for Treating Diabetes and other Serious Inflammatory Disorders
READ MORE

03.13.13
Islet Sciences Announces Important Study Published in Diabetes Titled “Immune Intervention Reducing β-Cell Death in Type 1 Diabetes”

READ MORE

Islet Sciences Announces Inclusion in BioWorld Today Article --- NEW YORK. NY, January 8, 2013 --Islet Sciences, Inc., (ISLT) a clinical stage...Learn More

Islet Sciences 6601 Six Forks Rd #140, Raleigh, NC 27615 Phone: 919.480.1518
Islet Sciences © 2011-2014 · Privacy Policy